ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20-Yet Progress Continues.

Esther S Frisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.